Jennifer Winter

Dr. Jennifer Winter


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2014 in The EMBO Journal
Verified
Journal Article
Closed access
PDF file
LRLuciano Rago
Luciano Rago
Robert BeattieRobert Beattie
Robert Beattie
VTVerdon Taylor
Verdon Taylor
JWJennifer Winter
Jennifer Winter

1 January 2015 in Neurogenesis
Verified
Journal Article
Open access
JWJennifer Winter
Jennifer Winter
The imprinted miR379–410 cluster contains 38 microRNAs (miRNAs) that are involved in diverse neurodevelopmental processes and are important regulators of neuronal function. The implications of these miRNAs in neurological diseases have been recently recognized.In the present minireview, the current findings regarding the brain-specific functions of miR379–410 cluster miRNAs are summarized and discussed.

10 September 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CBChristien Bräutigam
Christien Bräutigam
ARAngelo Raggioli
Angelo Raggioli
JWJennifer Winter
Jennifer Winter
MicroRNAs of the miR-302 cluster are involved in early embryonic development and somatic cell reprogramming. Expression of the miR-302 gene is regulated by the binding of the pluripotency factors Oct4, Sox2 and Nanog to the miR-302 promoter. The specific expression pattern of the miR-302 gene suggested that additional transcription factors might be involved in its regulation. Here, we show that the miR-302 promoter is a direct target of the Wnt/β-catenin signaling pathway. We found that the miR-302 promoter contains three different functional Tcf/Lef binding sites. Two of the three sites were located within the cluster of Oct4/Sox2/Nanog binding sites and were essential for Wnt/β-catenin-mediated regulation of the miR-302 gene. Tcf3, the only Tcf/Lef factor that bound to the miR-302 promoter, acted as a repressor of miR-302 transcription. Interestingly, mutations in the two Tcf/Lef binding sites and the Oct4/Nanog binding sites abolished miR-302 promoter responsiveness to Wnt signaling, suggesting that the Tcf/Lef and the Oct4/Nanog sites interact genetically.

24 January 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
ACAlexis Cooper
Alexis Cooper
TBTamer Butto
Tamer Butto
NHNiklas Hammer
Niklas Hammer
SJSomanath Jagannath
Somanath Jagannath
DFDesiree Lucia Fend-Guella
Desiree Lucia Fend-Guella
SSSusann Schweiger
Susann Schweiger
Mutations in the actively expressed, maternal allele of the imprinted KCNK9 gene cause Birk-Barel intellectual disability syndrome (BBIDS). Using a BBIDS mouse model, we identify here a partial rescue of the BBIDS-like behavioral and neuronal phenotypes mediated via residual expression from the paternal Kcnk9 (Kcnk9pat) allele. We further demonstrate that the second-generation HDAC inhibitor CI-994 induces enhanced expression from the paternally silenced Kcnk9 allele and leads to a full rescue of the behavioral phenotype suggesting CI-994 as a promising molecule for BBIDS therapy. Thus, these findings suggest a potential approach to improve cognitive dysfunction in a mouse model of an imprinting disorder.

29 June 2023 in EMBO Reports
Verified
Journal Article
Open access
BABismark Appiah
Bismark Appiah
CFCamila L Fullio
Camila L Fullio
COChiara Ossola
Chiara Ossola
IBIlaria Bertani
Ilaria Bertani
ERElena Restelli
Elena Restelli
TVTanja Vogel
Tanja Vogel
Cortical neurogenesis depends on the balance between self-renewal and differentiation of apical progenitors (APs). Here, we study the epigenetic control of AP's division mode by focusing on the enzymatic activity of the histone methyltransferase DOT1L. Combining lineage tracing with single-cell RNA sequencing of clonally related cells, we show at the cellular level that DOT1L inhibition increases neurogenesis driven by a shift of APs from asymmetric self-renewing to symmetric neurogenic consumptive divisions. At the molecular level, DOT1L activity prevents AP differentiation by promoting transcription of metabolic genes. Mechanistically, DOT1L inhibition reduces activity of an EZH2/PRC2 pathway, converging on increased expression of asparagine synthetase (ASNS), a microcephaly associated gene. Overexpression of ASNS in APs phenocopies DOT1L inhibition, and also increases neuronal differentiation of APs. Our data suggest that DOT1L activity/PRC2 crosstalk controls AP lineage progression by regulating asparagine metabolism.

30 March 2023 in Cells
Verified
Journal Article
Open access
PDF file
TBTamer Butto
Tamer Butto
KMKanak Mungikar
Kanak Mungikar
PBPeter Baumann
Peter Baumann
JWJennifer Winter
Jennifer Winter
BLBeat Lutz
Beat Lutz
SGSusanne Gerber
Susanne Gerber
In the last decade, we have witnessed an upsurge in nuclei-based studies, particularly coupled with next-generation sequencing. Such studies aim at understanding the molecular states that exist in heterogeneous cell populations by applying increasingly more affordable sequencing approaches, in addition to optimized methodologies developed to isolate and select nuclei. Although these powerful new methods promise unprecedented insights, it is important to understand and critically consider the associated challenges. Here, we provide a comprehensive overview of the rise of nuclei-based studies and elaborate on their advantages and disadvantages, with a specific focus on their utility for transcriptomic sequencing analyses. Improved designs and appropriate use of the various experimental strategies will result in acquiring biologically accurate and meaningful information.